Patent ID: 8263562

Claim:
A method of treating immunological liver damage comprising administering to a patient in need thereof a therapeutically effective amount of a peptide having the sequence of Formula I or a pharmaceutically acceptable salt or ester thereof; Xaa1-Gln-Xaa2-Xaa3-Thr-Ser-Gly-Xaa4 (Formula I) wherein, Xaa1 is absent, Ala, Gly, Val, Leu or Ile, Xaa2 is Thr or Ser, Xaa3 is Tyr, Phe or Trp, Xaa4 is absent, Ala, Gly, Val, Leu, Ile or Pro, and wherein the immunological liver damage is BCG vaccine and lipopolysaccharide-induced immunological liver damage.